July 2014 FDA Recall Drug by Ben Venue Laboratories Inc
D-1543-2014 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Ben Venue Laboratories Inc on July 31, 2014 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1543-2014

Reason for Recall
Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.
Initiated
07-31-2014
Reported
08-27-2014
Quantity
7172 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Ben Venue Laboratories Inc
CYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by Bedford Laboratories, Bedford, OH 44146, Manufactured by Ben Venue Labs, Inc., Bedford, OH 44146, NDC 55390-808-01

Batch or Lot Expiration Information

Lot# 0161-13-2167551; Exp. 07/14
Lot# 0161-13-2176919; Exp. 08/14